Association between serum arsenic and oral cancer risk: A case‐control study in southeast China

Objectives Evidence on serum arsenic and oral cancer risk was limited. We aimed to evaluate the association between serum arsenic and the risk of oral cancer in a southeast China population. Methods Serum arsenic was determined for 325 oral cancer patients and 648 controls using inductively coupled...

Full description

Saved in:
Bibliographic Details
Published in:Community dentistry and oral epidemiology 2022-04, Vol.50 (2), p.83-90
Main Authors: Chen, Qing, Qiu, Yu, Chen, Lin, Lin, Jing, Yan, Ling‐jun, Bao, Xiao‐dan, Lin, Li‐song, Pan, Li‐zhen, Shi, Bin, Zheng, Xiao‐yan, Chen, Fa, He, Bao‐chang, Wang, Jing, Liu, Feng‐qiong
Format: Article
Language:English
Subjects:
Arsenic
Arsenic - adverse effects
Arsenic - analysis
Case-Control Studies
China - epidemiology
Dietary intake
Humans
inductively coupled plasma mass spectrometry
Mass spectroscopy
Mouth Neoplasms - epidemiology
Mouth Neoplasms - etiology
Odds Ratio
Oral cancer
restricted cubic spline
serum arsenic
Smoking
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives Evidence on serum arsenic and oral cancer risk was limited. We aimed to evaluate the association between serum arsenic and the risk of oral cancer in a southeast China population. Methods Serum arsenic was determined for 325 oral cancer patients and 648 controls using inductively coupled plasma‐mass spectrometry (ICP‐MS). Logistic regression and restricted cubic spline were analysed the association between serum arsenic level and oral cancer risk, and crude and adjusted odds ratios (aOR) with 95% confidence interval (95% CI) were calculated. Factors adjusted for included age, gender, BMI, smoking, drinking, education, residence, marital status and dietary factors. Stratification analysis was further performed according to drinking, smoking and dietary characteristics. Results Serum arsenic level was lower in the case group (P50 = 19.2μg/L, IQR = 11.6 ~ 26.4μg/L) than in the control group (P50 = 30.2 μg/L, IQR = 25.0 ~ 36.4 μg/L). An inverse but nonlinear association was observed between arsenic level and oral cancer risk by restricted cubic spline. These with moderate serum arsenic levels had a lower risk of oral cancer than those with low levels (OR = 0.11; 95%CI: 0.07‐0.18), after adjusting for demographic and dietary intake factors. We also kept serum arsenic as a continuous variable in a regression model, where a similar inverse association between arsenic and oral cancer was observed, with OR = 0.86 (95%CI: 0.84‐0.88). Stratification analysis revealed no significant multiplicative interactions between serum arsenic and smoking, drinking or dietary intake. Conclusion Serum arsenic is inversely related to oral cancer risk. Relative to those with low levels of arsenic, people with moderate serum arsenic levels had a lower risk of oral cancer. If confirmed, serum arsenic level may be a useful predictive marker for oral cancer risk.
ISSN:0301-5661
1600-0528
DOI:10.1111/cdoe.12633